Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-01

FDA Approved: MESALAMINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves a supplemental application for Mesalamine from Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)